Literature DB >> 9502769

Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations.

J Wang1, D J Freeman, S M Grundy, D M Levine, R Guerra, J C Cohen.   

Abstract

Interindividual differences in plasma low-density lipoprotein cholesterol (LDL-C) levels reflect both environmental variation and genetic polymorphism, but the specific genes involved and their relative contributions to the variance in LDL-C are not known. In this study we investigated the relationship between plasma LDL-C concentrations and three genes with pivotal roles in LDL metabolism: the low-density lipoprotein receptor (LDLR), apolipoprotein B (APOB), and cholesterol 7alpha-hydroxylase (CYP7). Analysis of 150 nuclear families indicated statistically significant linkage between plasma LDL-C concentrations and CYP7, but not LDLR or APOB. Further sibling pair analyses using individuals with high plasma LDL-C concentrations as probands indicated that the CYP7 locus was linked to high plasma LDL-C, but not to low plasma LDL-C concentrations. This finding was replicated in an independent sample. DNA sequencing revealed two linked polymorphisms in the 5' flanking region of CYP7. The allele defined by these polymorphisms was associated with increased plasma LDL-C concentrations, both in sibling pairs and in unrelated individuals. Taken together, these findings indicate that polymorphism in CYP7 contributes to heritable variation in plasma LDL-C concentrations. Common polymorphisms in LDLR and APOB account for little of the heritable variation in plasma LDL-C concentrations in the general population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502769      PMCID: PMC508682          DOI: 10.1172/JCI1343

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.

Authors:  C J Glueck; S Ford; D Scheel; P Steiner
Journal:  JAMA       Date:  1972-11-06       Impact factor: 56.272

2.  Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man.

Authors:  N E Miller; P Clifton-Bligh; P J Nestel
Journal:  J Lab Clin Med       Date:  1973-12

3.  Lipoprotein lipid alterations with cholestyramine administration.

Authors:  R J Jones; L Dobrilovic
Journal:  J Lab Clin Med       Date:  1970-06

4.  Extensions to multivariate normal models for pedigree analysis.

Authors:  J L Hopper; J D Mathews
Journal:  Ann Hum Genet       Date:  1982-10       Impact factor: 1.670

5.  The investigation of linkage between a quantitative trait and a marker locus.

Authors:  J K Haseman; R C Elston
Journal:  Behav Genet       Date:  1972-03       Impact factor: 2.805

6.  A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol.

Authors:  R Guerra; J Wang; S M Grundy; J C Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

7.  A peroxidase-coupled method for the colorimetric determination of serum triglycerides.

Authors:  M W McGowan; J D Artiss; D R Strandbergh; B Zak
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

8.  Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences.

Authors:  M A Austin; M C King; R D Bawol; S B Hulley; G D Friedman
Journal:  Am J Epidemiol       Date:  1987-02       Impact factor: 4.897

9.  On the possible use of the serum level of 7 alpha-hydroxycholesterol as a marker for increased activity of the cholesterol 7 alpha-hydroxylase in humans.

Authors:  I Björkhem; E Reihnér; B Angelin; S Ewerth; J E Akerlund; K Einarsson
Journal:  J Lipid Res       Date:  1987-08       Impact factor: 5.922

10.  Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). A dose-response study of the effects of cholestyramine in hypercholesterolaemia.

Authors:  B Vessby; G Kostner; H Lithell; J Thomis
Journal:  Atherosclerosis       Date:  1982-07       Impact factor: 5.162

View more
  27 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate.

Authors:  Jian Shen; Donna K Arnett; Laurence D Parnell; Chao-Qiang Lai; Robert J Straka; Paul N Hopkins; Ping An; Mary F Feitosa; José M Ordovás
Journal:  J Cardiovasc Pharmacol       Date:  2012-03       Impact factor: 3.105

Review 3.  Human CYP7A1 deficiency: progress and enigmas.

Authors:  Anne Beigneux; Alan F Hofmann; Stephen G Young
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

4.  Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population.

Authors:  Susumu Saito; Aritoshi Iida; Akihiro Sekine; Saori Kawauchi; Shoko Higuchi; Chie Ogawa; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2003-04-29       Impact factor: 3.172

5.  Association of Common Single Nucleotide Polymorphisms of Candidate Genes with Gallstone Disease: A Meta-Analysis.

Authors:  Tripty Chauhan; R D Mittal; B Mittal
Journal:  Indian J Clin Biochem       Date:  2019-05-15

6.  Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis.

Authors:  Betsy C Wertheim; Jeffrey W Smith; Changming Fang; David S Alberts; Peter Lance; Patricia A Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2011-11-04

7.  Comparison of linkage-disequilibrium methods for localization of genes influencing quantitative traits in humans.

Authors:  G P Page; C I Amos
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

8.  Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients.

Authors:  Núria Roglans; Manuel Vázquez-Carrera; Marta Alegret; Ferran Novell; Daniel Zambón; Emilio Ros; Juan C Laguna; Rosa M Sánchez
Journal:  Eur J Clin Pharmacol       Date:  2003-12-18       Impact factor: 2.953

Review 9.  Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering.

Authors:  Irina A Pikuleva
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-11       Impact factor: 4.481

10.  Genetic variation and atherosclerosis.

Authors:  Erik Biros; Mirko Karan; Jonathan Golledge
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.